Collegium Pharmaceutical Inc
COLL
Market Cap$975.52M
Close$
$17.40
46.2% downside
Current Fair Value
46.2% downsideOvervalued by 46.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $975.52 Million |
|---|---|
| Enterprise Value | $1.74 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $2.14 |
| Beta | 0.65 |
| Outstanding Shares | 31,793,739 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 21.98 |
|---|---|
| PEG | -24.08 |
| Price to Sales | 1.62 |
| Price to Book Ratio | 4.62 |
| Enterprise Value to Revenue | 2.62 |
| Enterprise Value to EBIT | 11.91 |
| Enterprise Value to Net Income | 39 |
| Total Debt to Enterprise | 0.49 |
| Debt to Equity | 3.68 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Collegium Pharmaceutical Inc
CEO: Joseph Ciaffoni